Estrella Immunopharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Estrella Immunopharma schedules its combined 2025/2026 annual meeting of stockholders for June 29, 2026, to ratify the appointment of its independent auditor.